Cinobufagin targets POU6F1 to downregulate LINC01410-mediated proliferation and metastasis in osteosarcoma

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated deep summary by claude@2026-06, 2026-06-24 · read from full text

The preprint investigated how cinobufagin (CBG), a bioactive compound from toad venom, affects osteosarcoma by modulating long non-coding RNA pathways, using osteosarcoma cell lines treated with CBG and RNA sequencing to identify CBG-regulated lncRNAs. CBG was found to inhibit osteosarcoma proliferation, migration, invasion, and lung metastasis in xenograft and lung metastasis mouse models, with LINC01410 identified as a key oncogenic lncRNA downregulated by CBG. Mechanistically, CBG was reported to directly bind the transcription factor POU6F1, reducing its promoter occupancy of LINC01410 and thereby inactivating PI3K/AKT/mTOR signaling, supported by proteome microarray, docking, microscale thermophoresis, chromatin immunoprecipitation, and dual-luciferase reporter assays. A major caveat is that the work is a Research Square preprint and has not been peer reviewed. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Background Venenum bufonis (VB) is a traditional Chinese medicine (TCM) extracted from toad venom that has been used to treat various tumours. Cinobufagin (CBG), a major bioactive compound derived from the VB, has demonstrated clinical efficacy against metastatic bone tumours, but its LncRNA-modulating mechanisms in osteosarcoma (OS) remain unknown.This study investigates a novel mechanism by which CBG exerts its anti-tumor effects through targeting long non-coding RNAs (LncRNAs). Methods OS cell lines were treated with CBG. A series of cell biological experiments were performed to detect the effects of CBG on the proliferation, migration and invasion of osteosarcoma cells. RNA sequencing identified CBG-regulated lncRNAs. Proteome microarray analysis was used to screen for transcription factors that bind to CBG. Molecular docking and microscale thermophoresis experiments confirmed the binding of CBG to POU6F1. Chromatin immunoprecipitation and dual-luciferase reporter assays validated POU6F1 binding and the transcriptional regulation of LINC01410. In vivo , the efficacy of CBG in the treatment of OS proliferation and pulmonary metastasis was evaluated in subcutaneous xenograft and lung metastasis models. Results The experimental results show that CBG inhibits the malignant progression of OS, including proliferation and lung metastasis. RNA-seq revealed that LINC01410 is a key oncogenic lncRNA downregulated by CBG. Mechanistically, CBG directly binds to the transcription factor POU6F1 and inhibits its occupancy of the LINC01410 promoter, thereby inhibiting PI3K/AKT/mTOR signalling. Our study provides the first evidence for the mechanism by which CBGs target lncRNAs. Conclusions CBG exerts anti-OS effects by disrupting POU6F1-mediated transcription of LINC01410, thereby inactivating PI3K/AKT/mTOR signalling. This study supports the development of CBG as a therapeutic agent derived from TCM.
Full text 23,161 characters · extracted from preprint-html · click to expand
Cinobufagin targets POU6F1 to downregulate LINC01410-mediated proliferation and metastasis in osteosarcoma | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Cinobufagin targets POU6F1 to downregulate LINC01410-mediated proliferation and metastasis in osteosarcoma Bingxia Zhang, Liqin Yang, Yang Liu, Zidong Ma, Mridul Roy, Yufei Ma, and 4 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7976755/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background Venenum bufonis (VB) is a traditional Chinese medicine (TCM) extracted from toad venom that has been used to treat various tumours. Cinobufagin (CBG), a major bioactive compound derived from the VB, has demonstrated clinical efficacy against metastatic bone tumours, but its LncRNA-modulating mechanisms in osteosarcoma (OS) remain unknown.This study investigates a novel mechanism by which CBG exerts its anti-tumor effects through targeting long non-coding RNAs (LncRNAs). Methods OS cell lines were treated with CBG. A series of cell biological experiments were performed to detect the effects of CBG on the proliferation, migration and invasion of osteosarcoma cells. RNA sequencing identified CBG-regulated lncRNAs. Proteome microarray analysis was used to screen for transcription factors that bind to CBG. Molecular docking and microscale thermophoresis experiments confirmed the binding of CBG to POU6F1. Chromatin immunoprecipitation and dual-luciferase reporter assays validated POU6F1 binding and the transcriptional regulation of LINC01410. In vivo , the efficacy of CBG in the treatment of OS proliferation and pulmonary metastasis was evaluated in subcutaneous xenograft and lung metastasis models. Results The experimental results show that CBG inhibits the malignant progression of OS, including proliferation and lung metastasis. RNA-seq revealed that LINC01410 is a key oncogenic lncRNA downregulated by CBG. Mechanistically, CBG directly binds to the transcription factor POU6F1 and inhibits its occupancy of the LINC01410 promoter, thereby inhibiting PI3K/AKT/mTOR signalling. Our study provides the first evidence for the mechanism by which CBGs target lncRNAs. Conclusions CBG exerts anti-OS effects by disrupting POU6F1-mediated transcription of LINC01410, thereby inactivating PI3K/AKT/mTOR signalling. This study supports the development of CBG as a therapeutic agent derived from TCM. Cinobufagin Osteosarcoma LINC01410 POU6F1 PI3K/AKT/mTOR pathway Full Text Additional Declarations No competing interests reported. Supplementary Files Supplementaryprimerssequence.docx Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7976755","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":542948297,"identity":"a2ab02f4-b504-48f1-aa3c-8902a83049a5","order_by":0,"name":"Bingxia Zhang","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAxklEQVRIiWNgGAWjYBACNvb2gw8+VPy3Y2NmPkCcFj6eM8mGM84wJ/OztyUQp0VOIsFMmLONmXFmzxkDIh3GcyCNmYGNjdngRs7HG28Y7OR0GwhpYW889riAh4fP4EbuZss5DMnGZgcI25JuPENCAmhL7jZpHoYDidsIagH6RZrHwIBxw42cZ6RoSUgAeZ+NSC3gQD5wABTIxpZzDIjwi3w7MCo//jsAisqHN95U2MkR1IICJHiIjBpkLaTqGAWjYBSMghEBAE9AQYyjD0lIAAAAAElFTkSuQmCC","orcid":"","institution":"The First Affiliated Hospital of Henan Medical University","correspondingAuthor":true,"prefix":"","firstName":"Bingxia","middleName":"","lastName":"Zhang","suffix":""},{"id":542948298,"identity":"d410ee9c-5332-4c32-888a-367c11e8fc61","order_by":1,"name":"Liqin Yang","email":"","orcid":"","institution":"The First Affiliated Hospital of Henan Medical University","correspondingAuthor":false,"prefix":"","firstName":"Liqin","middleName":"","lastName":"Yang","suffix":""},{"id":542948300,"identity":"d295d7c0-26db-460b-8f33-b8033c68bd3f","order_by":2,"name":"Yang Liu","email":"","orcid":"","institution":"The First Affiliated Hospital of Henan Medical University","correspondingAuthor":false,"prefix":"","firstName":"Yang","middleName":"","lastName":"Liu","suffix":""},{"id":542948301,"identity":"fcc04c65-1daa-4216-a27f-74d7d1fac67b","order_by":3,"name":"Zidong Ma","email":"","orcid":"","institution":"The First Affiliated Hospital of Henan Medical University","correspondingAuthor":false,"prefix":"","firstName":"Zidong","middleName":"","lastName":"Ma","suffix":""},{"id":542948302,"identity":"5a28cb75-f4e1-4f18-bb62-252db65c5578","order_by":4,"name":"Mridul Roy","email":"","orcid":"","institution":"The First Affiliated Hospital of Henan Medical University","correspondingAuthor":false,"prefix":"","firstName":"Mridul","middleName":"","lastName":"Roy","suffix":""},{"id":542948303,"identity":"0a21091e-ae26-42cb-8994-9d79fc1cef1e","order_by":5,"name":"Yufei Ma","email":"","orcid":"","institution":"The First Affiliated Hospital of Henan Medical University","correspondingAuthor":false,"prefix":"","firstName":"Yufei","middleName":"","lastName":"Ma","suffix":""},{"id":542948304,"identity":"d856e43e-e076-4573-972b-16e8e57cf95d","order_by":6,"name":"Jiaqi Lu","email":"","orcid":"","institution":"The First Affiliated Hospital of Henan Medical University","correspondingAuthor":false,"prefix":"","firstName":"Jiaqi","middleName":"","lastName":"Lu","suffix":""},{"id":542948305,"identity":"58738905-35a0-45a2-a7ee-7e4c88f09963","order_by":7,"name":"Xiaoxia Yan","email":"","orcid":"","institution":"Luoyang Orthopedic-Traumatological Hospital of Henan Province","correspondingAuthor":false,"prefix":"","firstName":"Xiaoxia","middleName":"","lastName":"Yan","suffix":""},{"id":542948309,"identity":"e228e7ff-7e38-45d6-b75a-325f3b59faf3","order_by":8,"name":"Fei Cao","email":"","orcid":"","institution":"The First Affiliated Hospital of Henan Medical University","correspondingAuthor":false,"prefix":"","firstName":"Fei","middleName":"","lastName":"Cao","suffix":""},{"id":542948312,"identity":"81b2f644-c74a-457a-96f9-5242a6c7804c","order_by":9,"name":"Xiaohong Kang","email":"","orcid":"","institution":"The First Affiliated Hospital of Henan Medical University","correspondingAuthor":false,"prefix":"","firstName":"Xiaohong","middleName":"","lastName":"Kang","suffix":""}],"badges":[],"createdAt":"2025-10-29 07:23:30","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7976755/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7976755/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":96244886,"identity":"32b3b8b6-472b-4c65-94ed-eac89a7cb731","added_by":"auto","created_at":"2025-11-19 07:19:30","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":8099965,"visible":true,"origin":"","legend":"","description":"","filename":"Manuscript2025.10.31.docx","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/77298c5c5e41abc21757b00c.docx"},{"id":96244723,"identity":"1c262a5b-361f-4722-84cf-44415c6a39b0","added_by":"auto","created_at":"2025-11-19 07:19:07","extension":"docx","order_by":1,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":17190,"visible":true,"origin":"","legend":"","description":"","filename":"Supplementaryprimerssequence.docx","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/7b9c91bfe65f161be78b81e7.docx"},{"id":95949712,"identity":"12d6fc72-b5f9-45a3-b28a-1ce635cd71e8","added_by":"auto","created_at":"2025-11-14 18:56:18","extension":"json","order_by":2,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":10917,"visible":true,"origin":"","legend":"","description":"","filename":"ee80a88fca144200aac9a12b13a03cc1.json","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/4b9a14f91a7d219f35575282.json"},{"id":95949727,"identity":"90fbf418-e356-420d-8e1a-7955f2ca3e9f","added_by":"auto","created_at":"2025-11-14 18:56:19","extension":"tif","order_by":3,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":20851228,"visible":true,"origin":"","legend":"","description":"","filename":"Figures1.tif","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/e731fd1579fc3318789db16c.tif"},{"id":95949715,"identity":"07116108-e76e-4d2a-b755-f5d4878b27b7","added_by":"auto","created_at":"2025-11-14 18:56:18","extension":"xml","order_by":4,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":135227,"visible":true,"origin":"","legend":"","description":"","filename":"ee80a88fca144200aac9a12b13a03cc11enriched.xml","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/8c4130b8b2d2cf0da44591b3.xml"},{"id":95949726,"identity":"b10b8881-f239-4316-adec-bbde89e1d295","added_by":"auto","created_at":"2025-11-14 18:56:18","extension":"jpeg","order_by":5,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":5474260,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage1.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/c6e8083eb2234741a5a46fc5.jpeg"},{"id":96245461,"identity":"950e947f-9467-46ce-85de-c8a28d9520eb","added_by":"auto","created_at":"2025-11-19 07:20:42","extension":"jpeg","order_by":6,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":8378644,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage2.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/d9cf4e8bb5f6f91dcd290f1a.jpeg"},{"id":96245468,"identity":"4848f31a-bc6c-44e2-a445-37b78771c1e9","added_by":"auto","created_at":"2025-11-19 07:20:42","extension":"jpeg","order_by":7,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":4384600,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage3.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/a7e484041cbf581849c87aa7.jpeg"},{"id":95949720,"identity":"4dbbf03e-dfb1-4ff1-aa0c-416bc29cfa2b","added_by":"auto","created_at":"2025-11-14 18:56:18","extension":"jpeg","order_by":8,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":8148176,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage4.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/e2dba9942d8903aad8bdbd07.jpeg"},{"id":96244940,"identity":"cd840781-6f09-447d-b8b3-f4512b981c60","added_by":"auto","created_at":"2025-11-19 07:19:35","extension":"jpeg","order_by":9,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":4835956,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage5.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/7c8c3d4cc30788203a6468de.jpeg"},{"id":95949730,"identity":"8b60eccb-995c-4ab6-8238-8d48952e151c","added_by":"auto","created_at":"2025-11-14 18:56:19","extension":"jpeg","order_by":10,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":2516674,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage6.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/facee9e79f94442a06b0404c.jpeg"},{"id":95949717,"identity":"bcbcb169-5e9d-49a1-bde8-e9f83bf21a39","added_by":"auto","created_at":"2025-11-14 18:56:18","extension":"png","order_by":11,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":187356,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage7.png","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/8325b441f01a13aabaed97ac.png"},{"id":96244894,"identity":"cf4e7f1e-eeed-4c73-911c-d693e1aab68f","added_by":"auto","created_at":"2025-11-19 07:19:30","extension":"png","order_by":12,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":311540,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage1.png","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/269f747c6570e5965cdb1213.png"},{"id":96243843,"identity":"f83ea6f1-ba47-41d2-a540-d1ff7ea6cd7f","added_by":"auto","created_at":"2025-11-19 07:17:09","extension":"png","order_by":13,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":362720,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage2.png","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/aa3d32e77b960783a7bfc0b9.png"},{"id":96245755,"identity":"f8b66df8-f7ab-4f40-a09c-bca7354ea832","added_by":"auto","created_at":"2025-11-19 07:22:21","extension":"png","order_by":14,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":148662,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage3.png","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/22d389e5089318028f22b11e.png"},{"id":96244245,"identity":"a0727517-baa3-4261-9295-fdc5657b354d","added_by":"auto","created_at":"2025-11-19 07:18:00","extension":"png","order_by":15,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":420346,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage4.png","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/5b16105cbc719700529413b0.png"},{"id":96244798,"identity":"9c487b56-0b8b-4572-98dc-6ba6f34033ff","added_by":"auto","created_at":"2025-11-19 07:19:16","extension":"png","order_by":16,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":115269,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage5.png","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/25fd55675544c6c4d7ff8e32.png"},{"id":96244754,"identity":"534399b8-d50f-4fdc-af87-df47ac0e4524","added_by":"auto","created_at":"2025-11-19 07:19:09","extension":"png","order_by":17,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":33420,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage6.png","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/b4ded14c3f978796956d06e2.png"},{"id":95949713,"identity":"9e6e3c5a-22d6-433a-87b7-52e140c77375","added_by":"auto","created_at":"2025-11-14 18:56:18","extension":"png","order_by":18,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":31937,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage7.png","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/c573b4bbd4f339daa6907cc6.png"},{"id":96244659,"identity":"f4eb36ce-d2cf-4575-8901-2f9c91c0d4e6","added_by":"auto","created_at":"2025-11-19 07:19:01","extension":"xml","order_by":19,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":135817,"visible":true,"origin":"","legend":"","description":"","filename":"ee80a88fca144200aac9a12b13a03cc11structuring.xml","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/42a065d699f158a2f3ae965d.xml"},{"id":95949731,"identity":"bc0b0e16-f8a7-45a9-af1a-023859fb72de","added_by":"auto","created_at":"2025-11-14 18:56:19","extension":"html","order_by":20,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":145314,"visible":true,"origin":"","legend":"","description":"","filename":"earlyproof.html","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/7e7c343154e78a36539d7229.html"},{"id":99319721,"identity":"0a7d288d-9409-44ab-afe3-04c82afdb491","added_by":"auto","created_at":"2025-12-31 16:37:42","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":2174068,"visible":true,"origin":"","legend":"","description":"","filename":"Manuscript2025.10.31.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1_covered_4e2e0f3b-f901-489e-b400-0f62488473bb.pdf"},{"id":95949710,"identity":"e91a3328-bd8b-4d1b-81a2-d03e6cb25b6a","added_by":"auto","created_at":"2025-11-14 18:56:18","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":17190,"visible":true,"origin":"","legend":"","description":"","filename":"Supplementaryprimerssequence.docx","url":"https://assets-eu.researchsquare.com/files/rs-7976755/v1/1e31762c9ab72c55e99dd1c7.docx"}],"financialInterests":"No competing interests reported.","formattedTitle":"Cinobufagin targets POU6F1 to downregulate LINC01410-mediated proliferation and metastasis in osteosarcoma","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Cinobufagin, Osteosarcoma, LINC01410, POU6F1, PI3K/AKT/mTOR pathway","lastPublishedDoi":"10.21203/rs.3.rs-7976755/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7976755/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003ch2\u003eBackground\u003c/h2\u003e\u003cp\u003eVenenum bufonis (VB) is a traditional Chinese medicine (TCM) extracted from toad venom that has been used to treat various tumours. Cinobufagin (CBG), a major bioactive compound derived from the VB, has demonstrated clinical efficacy against metastatic bone tumours, but its LncRNA-modulating mechanisms in osteosarcoma (OS) remain unknown.This study investigates a novel mechanism by which CBG exerts its anti-tumor effects through targeting long non-coding RNAs (LncRNAs).\u003c/p\u003e\u003ch2\u003eMethods\u003c/h2\u003e\u003cp\u003eOS cell lines were treated with CBG. A series of cell biological experiments were performed to detect the effects of CBG on the proliferation, migration and invasion of osteosarcoma cells. RNA sequencing identified CBG-regulated lncRNAs. Proteome microarray analysis was used to screen for transcription factors that bind to CBG. Molecular docking and microscale thermophoresis experiments confirmed the binding of CBG to POU6F1. Chromatin immunoprecipitation and dual-luciferase reporter assays validated POU6F1 binding and the transcriptional regulation of LINC01410. \u003cem\u003eIn vivo\u003c/em\u003e, the efficacy of CBG in the treatment of OS proliferation and pulmonary metastasis was evaluated in subcutaneous xenograft and lung metastasis models.\u003c/p\u003e\u003ch2\u003eResults\u003c/h2\u003e\u003cp\u003eThe experimental results show that CBG inhibits the malignant progression of OS, including proliferation and lung metastasis. RNA-seq revealed that LINC01410 is a key oncogenic lncRNA downregulated by CBG. Mechanistically, CBG directly binds to the transcription factor POU6F1 and inhibits its occupancy of the LINC01410 promoter, thereby inhibiting PI3K/AKT/mTOR signalling. Our study provides the first evidence for the mechanism by which CBGs target lncRNAs.\u003c/p\u003e\u003ch2\u003eConclusions\u003c/h2\u003e\u003cp\u003eCBG exerts anti-OS effects by disrupting POU6F1-mediated transcription of LINC01410, thereby inactivating PI3K/AKT/mTOR signalling. This study supports the development of CBG as a therapeutic agent derived from TCM.\u003c/p\u003e","manuscriptTitle":"Cinobufagin targets POU6F1 to downregulate LINC01410-mediated proliferation and metastasis in osteosarcoma","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-11-14 18:56:13","doi":"10.21203/rs.3.rs-7976755/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"cc56f25d-c181-476f-b2f3-153e85988530","owner":[],"postedDate":"November 14th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2025-12-30T19:08:54+00:00","versionOfRecord":[],"versionCreatedAt":"2025-11-14 18:56:13","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-7976755","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7976755","identity":"rs-7976755","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-26T02:00:01.498150+00:00
License: CC-BY-4.0